Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers.

MLA

Cousins, Katheryn A. Q., et al. “Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers.” JAMA Neurology, vol. 79, no. 11, Nov. 2022, pp. 1155–64. EBSCOhost, https://doi.org/10.1001/jamaneurol.2022.3265.

APA

Cousins, K. A. Q., Shaw, L. M., Chen-Plotkin, A., Wolk, D. A., Van Deerlin, V. M., Lee, E. B., McMillan, C. T., Grossman, M., & Irwin, D. J. (2022). Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers. JAMA Neurology, 79(11), 1155–1164. https://doi.org/10.1001/jamaneurol.2022.3265

Chicago

Cousins, Katheryn A Q, Leslie M Shaw, Alice Chen-Plotkin, David A Wolk, Vivianna M Van Deerlin, Edward B Lee, Corey T McMillan, Murray Grossman, and David J Irwin. 2022. “Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers.” JAMA Neurology 79 (11): 1155–64. doi:10.1001/jamaneurol.2022.3265.